BlueCrest Capital Management’s Myriad Genetics MYGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-7,200	Closed	-$239K	–	822
2019 Q1	$239K	Buy	+7,200	New	+$239K	0.01%	832